Extendicare Inc's stock surged by 2.67% in the last trading session, reflecting positive investor sentiment and potential growth opportunities.
In a notable performance on the TSX, Extendicare Inc (EXE.TO) saw its stock price rise by 2.67%, closing at CA$33.87. This uptick can be attributed to the company's strategic moves in the healthcare sector, particularly in home health care and acquisitions, which have bolstered investor confidence.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.48B
P/E
26.1x
Div. yield
1.39%
Div. / share
$0.51
52W high
$39.09
52W low
$11.99
1W change
-7.56%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 9.5% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.83
+9.5% Upside
Current Price
C$35.48
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
28.7%
Annualized
90-Day Vol
34.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$42.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$37.66 | C$34.11 – C$41.57 |
| 60 trading days | C$39.97 | C$34.75 – C$45.97 |
| 90 trading days | C$42.42 | C$35.74 – C$50.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on Extendicare's growth strategies and financial performance, as they may signal further positive momentum in the stock.
Extendicare Inc Market Cap Reaches CA$3.21 Billion
With a market cap of CA$3.21 billion and a P/E ratio of 24.26, Extendicare is positioned as a significant player in the healthcare market, reflecting its growth potential.
Bull case
Extendicare's recent acquisitions and growth in home health care services make it a strong candidate for future profitability. This positions the company as an appealing option for investors looking to enter the healthcare sector.
Bear case
Despite the recent gains, investors should remain cautious about potential market volatility and challenges in the healthcare sector that could affect future performance.
Positive Market Reaction
Advertisement
The recent rise in Extendicare's stock is linked to its strategic initiatives aimed at expanding its presence in healthcare. Investors are responding positively to the company's focus on home health care and successful acquisitions, which are expected to enhance its services and profitability.
Growth Potential in Healthcare
Extendicare's market cap now stands at CA$3.21 billion, supported by a solid P/E ratio of 24.26. This positions the company as a formidable player in the healthcare industry, with potential for further growth as demand for healthcare services continues to rise. Investors should consider these metrics when evaluating their portfolios.
Looking Ahead
As Extendicare continues to implement its growth strategies, investors should closely monitor its financial performance. The company's recent moves, including acquisitions and a focus on expanding home health care services, could lead to sustained stock performance, making it a noteworthy option for those looking to invest in the healthcare sector. For more insights, check out the Extendicare Inc stock page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
